References
1. Bousquet J, Anto JM, Bachert C, Baiardini I, Bosnic-Anticevich S,
Walter Canonica G, et al. Allergic rhinitis. Nat Rev Dis Primers.
2020;6(1):95.
2. Galli SJ, Tsai M, Piliponsky AM. The development of allergic
inflammation. Nature. 2008;454(7203):445-54.
3. Serhan CN. Treating inflammation and infection in the 21st century:
new hints from decoding resolution mediators and mechanisms. FASEB J.
2017;31(4):1273-88.
4. Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways
of airway inflammation in asthma. Pharmacol Ther. 2018;186:98-113.
5. Serhan CN. Resolution phase of inflammation: novel endogenous
anti-inflammatory and proresolving lipid mediators and pathways. Annu
Rev Immunol. 2007;25:101-37.
6. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA,
et al. Multi-pronged inhibition of airway hyper-responsiveness and
inflammation by lipoxin A(4). Nat Med. 2002;8(9):1018-23.
7. Karra L, Haworth O, Priluck R, Levy BD, Levi-Schaffer F. Lipoxin B(4)
promotes the resolution of allergic inflammation in the upper and lower
airways of mice. Mucosal Immunol. 2015;8(4):852-62.
8. Vachier I, Bonnans C, Chavis C, Farce M, Godard P, Bousquet J, et al.
Severe asthma is associated with a loss of LX4, an endogenous
anti-inflammatory compound. J Allergy Clin Immunol. 2005;115(1):55-60.
9. Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E,
et al. Diminished lipoxin biosynthesis in severe asthma. Am J Respir
Crit Care Med. 2005;172(7):824-30.
10. Campbell KS, Hasegawa J. Natural killer cell biology: an update and
future directions. J Allergy Clin Immunol. 2013;132(3):536-44.
11. Haworth O, Cernadas M, Levy BD. NK cells are effectors for resolvin
E1 in the timely resolution of allergic airway inflammation. J Immunol.
2011;186(11):6129-35.
12. Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, et al.
Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell
activation in asthma. Sci Transl Med. 2013;5(174):174ra26.
13. Awad A, Yassine H, Barrier M, Vorng H, Marquillies P, Tsicopoulos A,
et al. Natural killer cells induce eosinophil activation and apoptosis.
PLoS One. 2014;9(4):e94492.
14. Auge J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A, et
al. EAACI Position paper on the standardization of nasal allergen
challenges. Allergy. 2018;73(8):1597-608.
15. Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB.
Correlation between symptoms and the threshold for release of mediators
in nasal secretions during nasal challenge with grass-pollen grains. J
Allergy Clin Immunol. 1988;82(5 Pt 1):869-77.
16. Naclerio RM, Proud D, Togias AG, Adkinson NF, Jr., Meyers DA,
Kagey-Sobotka A, et al. Inflammatory mediators in late antigen-induced
rhinitis. N Engl J Med. 1985;313(2):65-70.
17. Brooks CR, van Dalen CJ, Hermans IF, Douwes J. Identifying leukocyte
populations in fresh and cryopreserved sputum using flow cytometry.
Cytometry B Clin Cytom. 2013;84(2):104-13.
18. Wacht G, Poirot A, Charles AL, Radosavljevic M, Uring-Lambert B, de
Blay F, et al. FACS - based isolation of human eosinophils allows
purification of high quality RNA. J Immunol Methods. 2018;463:47-53.
19. Soyombo O, Spur BW, Lee TH. Effects of lipoxin A4 on chemotaxis and
degranulation of human eosinophils stimulated by platelet-activating
factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy.
1994;49(4):230-4.
20. Bjorkstrom NK, Ljunggren HG, Michaelsson J. Emerging insights into
natural killer cells in human peripheral tissues. Nat Rev Immunol.
2016;16(5):310-20.
21. Korsgren M, Persson CG, Sundler F, Bjerke T, Hansson T, Chambers BJ,
et al. Natural killer cells determine development of allergen-induced
eosinophilic airway inflammation in mice. J Exp Med. 1999;189(3):553-62.
22. Ple C, Barrier M, Amniai L, Marquillies P, Bertout J, Tsicopoulos A,
et al. Natural killer cells accumulate in lung-draining lymph nodes and
regulate airway eosinophilia in a murine model of asthma. Scand J
Immunol. 2010;72(2):118-27.
23. Mathias CB, Guernsey LA, Zammit D, Brammer C, Wu CA, Thrall RS, et
al. Pro-inflammatory role of natural killer cells in the development of
allergic airway disease. Clin Exp Allergy. 2014;44(4):589-601.
24. Timonen T, Stenius-Aarniala B. Natural killer cell activity in
asthma. Clin Exp Immunol. 1985;59(1):85-90.
25. Mesdaghi M, Vodjgani M, Salehi E, Hadjati J, Sarrafnejad A, Bidad K,
et al. Natural killer cells in allergic rhinitis patients and nonatopic
controls. Int Arch Allergy Immunol. 2010;153(3):234-8.
26. El-Shazly AE, Doloriert HC, Bisig B, Lefebvre PP, Delvenne P, Jacobs
N. Novel cooperation between CX3CL1 and CCL26 inducing NK cell
chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of
the allergic nasal tissue. Clin Exp Allergy. 2013;43(3):322-31.
27. Mack MR, Brestoff JR, Berrien-Elliott MM, Trier AM, Yang TB,
McCullen M, et al. Blood natural killer cell deficiency reveals an
immunotherapy strategy for atopic dermatitis. Sci Transl Med.
2020;12(532).
28. Pesce S, Thoren FB, Cantoni C, Prato C, Moretta L, Moretta A, et al.
The Innate Immune Cross Talk between NK Cells and Eosinophils Is
Regulated by the Interaction of Natural Cytotoxicity Receptors with
Eosinophil Surface Ligands. Front Immunol. 2017;8:510.
29. Felton JM, Lucas CD, Dorward DA, Duffin R, Kipari T, Vermeren S, et
al. Mer-mediated eosinophil efferocytosis regulates resolution of
allergic airway inflammation. J Allergy Clin Immunol.
2018;142(6):1884-93 e6.
30. Klion AD, Ackerman SJ, Bochner BS. Contributions of Eosinophils to
Human Health and Disease. Annu Rev Pathol. 2020;15:179-209.
31. Chavis C, Vachier I, Chanez P, Bousquet J, Godard P.
5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in
human polymorphonuclear cells: dual specificity of 5-lipoxygenase
towards endogenous and exogenous precursors. J Exp Med.
1996;183(4):1633-43.
32. Ohkawara Y, Lei XF, Stampfli MR, Marshall JS, Xing Z, Jordana M.
Cytokine and eosinophil responses in the lung, peripheral blood, and
bone marrow compartments in a murine model of allergen-induced airways
inflammation. Am J Respir Cell Mol Biol. 1997;16(5):510-20.
33. Tomkinson A, Cieslewicz G, Duez C, Larson KA, Lee JJ, Gelfand EW.
Temporal association between airway hyperresponsiveness and airway
eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med.
2001;163(3 Pt 1):721-30.
34. Lommatzsch M, Julius P, Kuepper M, Garn H, Bratke K, Irmscher S, et
al. The course of allergen-induced leukocyte infiltration in human and
experimental asthma. J Allergy Clin Immunol. 2006;118(1):91-7.
35. Sugimoto MA, Vago JP, Perretti M, Teixeira MM. Mediators of the
Resolution of the Inflammatory Response. Trends Immunol.
2019;40(3):212-27.
36. Pazdrak K, Straub C, Maroto R, Stafford S, White WI, Calhoun WJ, et
al. Cytokine-Induced Glucocorticoid Resistance from Eosinophil
Activation: Protein Phosphatase 5 Modulation of Glucocorticoid Receptor
Phosphorylation and Signaling. J Immunol. 2016;197(10):3782-91.